Quotes
Quotes
NAVs
May 24, 2013
HOME
NEWS
Economy
Finance
Technology
Companies
International
General
SHARE BAZAAR
Overview
Top Gainers
Top Losers
Top Volume
Top Value
52-Week High/Low
Only Buyers
Only Sellers
Index Constituents
Sector Watch
Advances/Declines
ADR Prices
GDR Prices
Indices
Bulk Deals
Block Deals
Deliverable Volumes
No Delivery
Holiday List
Closing Prices
COMPANY WATCH
MUTUAL FUND
Overview
MF News
MF Watch
MF Gainers
MF Losers
Latest NAV
Scheme Profile
New Fund Offers
Forthcoming Issues
Closed Issues
Recent Dividends
Best Performers
Biggest Schemes
MF News
MF Concept
MF History
Important Links
FAQs in MF
Scheme Info
MF Announcements
MF Activity
Fund Mobilization
AUM Details
MF Bulk Deals
Bonus Details
MF Tools
Scheme Compare
Category Performance
Category Rankings
Performance Map
Performance Comparision
Portfolio Comparision
Fund Snapshot
DERIVATIVES
Overview
Top Gainers
Top Losers
Top Volume
Top Value
Highest In Premium
Most Active Calls
Most Active Puts
Most Active Contract
Open Interest
Put Call Ratio
Market Watch
FII Statistics
Historical Data
Derivative Watch
F&O Quotes
Settlement Prices
Underlyings
IPO
Overview
IPO Details
Issue Profile
Forthcoming IPOs
Open Issues
Closed Issues
Basis of Allotment
Draft Prospectus
New Listings
IPO Search By
Highest Permium
At Par
Industrywise
Yearwise
Lead Managerwise
Oversubscribed
Issue Size
State Zone
Price Performance
Market Watch
Only Buyers
Only Sellers
Market Movers
Offer Price
Price & Volume
Closing Prices
Average Price
High/Low
Bulk Deals
Announcements
News
Splits of Face Value
Board Meetings
AGM
Glossary
FAQs
Important Links
MANDI
Overview
Top Gainer
Top Losers
Top Volume
Top Value
Highest In OI
Lowest In OI
Increase In OI (%)
Decrease In OI (%)
Spot Top Gainers
Spot Top Losers
Advance Declines
Market Breadth
Commodity News
Closing Prices
Commodity Search
Commodity Indices
FOREX
BUDGET 2013
In-Focus
Bullion
Personal Finance
Property Plus
Gadgets & More
Wheelocity
Pics
Slideshows
Videos
Press Releases
biocon
Biocon to launch psoriasis drug novel biologic in July
"We plan to launch Alzumab (Itolizumab) in July this year in the country. It is a novel, first-in-class biologic for the treatment of psoriasis," Biocon Chairman and Managing Director Kiran Mazumdar-Shaw said in an interview.
Biocon Q4 consolidated net up over two-fold to Rs 248.61 crore
Consolidated net sales of the company, however, rose to Rs 630.12 crore for quarter ended March 31, 2013 from Rs 589.22 crore for the same period a year ago.
First
Prev
1
Next
Last
Top News
Most Read
Most Viewed
Google in talks to buy Waze for $1 bn: Report
Rupee down 10 paise at 55.69 against dollar
South Asian rights group concerned over US immigration bill
Gold price today: Latest updates
BlackBerry announces EMI schemes for BlackBerry Z10,Curve 9220
Pregnant Araceli Roiz to sue Phaneesh Murthy
Gold price today: Latest updates
Gold price today: Latest updates
Micromax A110Q Canvas 2 plus goes official
Sensex falls below 20K, down 388 points; SBI loses over 7%
Sensex tanks 430 points
Pregnant GF to sue Murthy, iGate
Pregnant GF to sue Murthy, iGate 7
Pregnant GF to sue Murthy, iGate 8
Pregnant GF to sue Murthy, iGate 3
Galleries
Chevrolet Enjoy
Sony Xperia L
Nokia Asha 210
Shanghai Auto Show
Nokia Lumia 720
Videos
more
Pregnant GF to sue Murthy, iGate
Sensex tanks 430 points
Contact Us
:
Privacy Policy
:
Legal Disclaimer
Copyright © Zee News Limited. All rights reserved